Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate

NCT01491711 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

162

Enrollment

OTHER

Sponsor class

Conditions

Superficial Basal Cell Carcinoma

Interventions

DRUG: Methylaminolevulinate PDT in 2 sessions
DRUG: Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT

Sponsor

Maastricht University Medical Center

Collaborators

[object Object]
[object Object]